Nelson Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-11
Closed -$1K 363
2019
Q2
$1K Buy
+11
New +$1.04K ﹤0.01% 297
2018
Q1
Sell
-24,949
Closed -$2.6M 341
2017
Q4
$2.6M Sell
24,949
-246
-1% -$27.8K 0.81% 43
2017
Q3
$3.67M Buy
25,195
+50
+0.2% +$6.81K 1.21% 40
2017
Q2
$3.27M Sell
25,145
-60
-0.2% -$7.35K 1.11% 42
2017
Q1
$3.14M Buy
25,205
+500
+2% +$59.8K 1.06% 44
2016
Q4
$2.86M Sell
24,705
-722
-3% -$80.4K 1% 46
2016
Q3
$2.66M Buy
25,427
+360
+1% +$39K 0.94% 44
2016
Q2
$2.47M Sell
25,067
-821
-3% -$84.9K 0.93% 43
2016
Q1
$2.59M Sell
25,888
-26,150
-50% -$2.69M 0.98% 44
2015
Q4
$6.23M Buy
52,038
+250
+0.5% +$28.9K 2.4% 13
2015
Q3
$5.6M Buy
51,788
+1,809
+4% +$224K 2.14% 20
2015
Q2
$5.78M Buy
49,979
+936
+2% +$107K 2.09% 19
2015
Q1
$5.65M Sell
49,043
-310
-0.6% -$37K 2.04% 20
2014
Q4
$5.52M Buy
49,353
+1,255
+3% +$132K 2.05% 22
2014
Q3
$4.56M Buy
48,098
+1,540
+3% +$139K 1.72% 27
2014
Q2
$4M Buy
46,558
+45,310
+3,631% +$3.45M 1.6% 29
2014
Q1
$87K Hold
1,248
0.04% 97
2013
Q4
$105K Hold
1,248
0.05% 89
2013
Q3
$96K Hold
1,248
0.05% 94
2013
Q2
$73K Buy
+1,248
New +$75.1K 0.04% 98

Other funds holding CELG

Nelson Capital Management's CELG Position: Q3 2019 in Review

Nelson Capital Management sold out of Celgene Corp (CELG) in Q3 2019, closing a stake of 11 shares — an estimated $1K sold.

Nelson Capital Management first reported a position in CELG in Q2 2013 and held it in 20 quarters. The position peaked at $6.23M in Q4 2015. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

  • Nelson Capital Management reported no remaining Celgene Corp position as of Q3 2019 after selling out during the quarter.
  • Nelson Capital Management sold 11 Celgene Corp shares in Q3 2019, an estimated $1K.
  • Nelson Capital Management first reported a position in Celgene Corp in Q2 2013 and held it in 20 quarters.
  • Nelson Capital Management's Celgene Corp position peaked at $6.23M in Q4 2015.
  • 1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on Nelson Capital Management's 13F filing for Q3 2019, filed 8 Nov 2019.